Back to Menu
1. Clinical presentation assessment
A detailed history is obtained regarding hematuria characteristics, pain features, and mass-related findings. Painless gross hematuria is an important warning sign.
2. Imaging examinations
Ultrasonography screens for cystic versus solid lesions. Contrast-enhanced CT evaluates vascularity and supports staging, while MRI is advantageous for assessing venous tumor thrombus.
3. Laboratory testing
Urinalysis assesses hematuria; complete blood count evaluates anemia; renal function testing is essential for treatment selection.
4. Pathological diagnosis
Histopathology of biopsy or surgical specimens is the gold standard, defining subtype and grade to guide clinical decision-making.
5. Tumor staging assessment
TNM staging is determined based on imaging, evaluating local invasion, lymph node involvement, and distant metastasis.
6. Renal function assessment
Renal scintigraphy and creatinine clearance assess split renal function and inform the choice between nephron-sparing and radical surgery.
7. Molecular diagnostic techniques
Genomic alterations and expression profiles provide prognostic information and potential targets for individualized therapy.
8. Differential diagnosis
Differentiation from benign tumors, infection, and cystic disease is required, relying primarily on imaging and pathological confirmation.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that kidney cancer is a common urinary tract malignancy with complex diagnostic pathways and significant health impact. Early diagnosis and precise classification are key to improving cure rates. Standardized, systematic diagnostic evaluation enables accurate disease assessment and guides individualized treatment. The public should remain vigilant for early warning signs, undergo regular health examinations, and seek timely medical evaluation when symptoms occur.
1. Clinical presentation assessment
A detailed history is obtained regarding hematuria characteristics, pain features, and mass-related findings. Painless gross hematuria is an important warning sign.
2. Imaging examinations
Ultrasonography screens for cystic versus solid lesions. Contrast-enhanced CT evaluates vascularity and supports staging, while MRI is advantageous for assessing venous tumor thrombus.
3. Laboratory testing
Urinalysis assesses hematuria; complete blood count evaluates anemia; renal function testing is essential for treatment selection.
4. Pathological diagnosis
Histopathology of biopsy or surgical specimens is the gold standard, defining subtype and grade to guide clinical decision-making.
5. Tumor staging assessment
TNM staging is determined based on imaging, evaluating local invasion, lymph node involvement, and distant metastasis.
6. Renal function assessment
Renal scintigraphy and creatinine clearance assess split renal function and inform the choice between nephron-sparing and radical surgery.
7. Molecular diagnostic techniques
Genomic alterations and expression profiles provide prognostic information and potential targets for individualized therapy.
8. Differential diagnosis
Differentiation from benign tumors, infection, and cystic disease is required, relying primarily on imaging and pathological confirmation.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that kidney cancer is a common urinary tract malignancy with complex diagnostic pathways and significant health impact. Early diagnosis and precise classification are key to improving cure rates. Standardized, systematic diagnostic evaluation enables accurate disease assessment and guides individualized treatment. The public should remain vigilant for early warning signs, undergo regular health examinations, and seek timely medical evaluation when symptoms occur.